Product Description: Bempikibart (ADX-914) is a human anti-IL-7Rα antibody. Bempikibart can be used for the research of anti-inflammatory[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]WHO Drug Information, International Nonproprietary Names for Pharmaceutical Substances (INN), Vol. 36, No. 2, 2022.
CAS Number: 2622254-57-1
Molecular Weight: N/A
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: Others